Sale!

SLC4A11 Gene Corneal endothelial dystrophy type 2 Genetic Test

4,400 د.إ

-21%

The SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, aimed at detecting mutations in the SLC4A11 gene, which are associated with the development of Corneal Endothelial Dystrophy Type 2 (CHED2). This condition is a rare, inherited eye disorder that primarily affects the endothelium, the innermost layer of the cornea, leading to swelling, blurred vision, and potentially severe visual impairment.

The test is crucial for individuals with a family history of CHED2 or those exhibiting symptoms, as early detection can facilitate timely management and treatment options to preserve vision. Conducted through a blood sample or buccal swab, the test specifically looks for genetic abnormalities in the SLC4A11 gene, which plays a significant role in maintaining corneal transparency and hydration.

Priced at 4400 AED, the genetic test at DNA Labs UAE is performed with high precision and accuracy, providing individuals and their healthcare providers with vital information for making informed decisions regarding the condition’s management and treatment. The test not only aids in the diagnosis but also helps in understanding the risk of passing the condition to future generations, thereby playing a significant role in family planning and genetic counseling.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test

Overview

The SLC4A11 gene is associated with corneal endothelial dystrophy type 2, a rare inherited disorder that affects the cornea. This disorder leads to malfunctioning of the corneal endothelial cells, resulting in clouding and decreased vision.

Genetic Test Details

The SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test is available at DNA Labs UAE. The test utilizes NGS (next-generation sequencing) technology to analyze multiple genes simultaneously, providing a comprehensive assessment of genetic variants associated with the disorder.

Test Components and Price

  • Test Name: SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test
  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: 4400.0 AED

Sample Condition

The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The test results are typically delivered within 3 to 4 weeks.

Method

The test utilizes NGS (next-generation sequencing) technology for analysis.

Test Type

The SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test falls under the category of Ophthalmology Disorders.

Doctor and Test Department

The test is conducted by an Ophthalmologist in the Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is undergoing the SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 NGS Genetic DNA Test. A Genetic Counselling session is recommended to draw a pedigree chart of family members affected by the disorder.

Test Usage

The SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test is useful for individuals with a family history of the disorder or those experiencing symptoms such as blurred vision or glare. It can also be used for carrier screening in individuals planning to have children.

Important Considerations

While genetic testing provides valuable information about the likelihood of developing a disorder, it cannot predict the severity or progression of the disorder. It is essential to interpret genetic testing results alongside other clinical and diagnostic information.

Test Name SLC4A11 Gene Corneal endothelial dystrophy type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC4A11 Gene Corneal endothelial dystrophy type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC4A11 Gene Corneal endothelial dystrophy type 2 NGS Genetic DNA Test gene SLC4A11
Test Details

The SLC4A11 gene is associated with corneal endothelial dystrophy type 2, which is a rare inherited disorder that affects the cornea. This disorder causes the corneal endothelial cells to malfunction, leading to clouding and decreased vision.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the SLC4A11 gene, which can confirm a diagnosis of corneal endothelial dystrophy type 2. This type of genetic testing involves analyzing multiple genes at once, allowing for a more comprehensive assessment of genetic variants that may be contributing to the disorder.

NGS genetic testing for corneal endothelial dystrophy type 2 can be useful for individuals who have a family history of the disorder or who are experiencing symptoms such as blurred vision or glare. This type of testing can also be used for carrier screening in individuals with a family history of the disorder who are considering having children.

It is important to note that while genetic testing can provide valuable information about the likelihood of developing a disorder, it cannot predict the severity or progression of the disorder. Additionally, genetic testing results should be interpreted in conjunction with other clinical and diagnostic information.